Mentions
Extended reach
Total likes
Video views
AI synopsis
The collection centers on optimistic appraisal of the article, highlighting potential for senolytics to transform geriatrics by addressing multiple diseases and functional declines. Posts frequently quote or paraphrase the authors to underline the translational potential and trial design innovations, signaling careful, forward-looking interest rather than critique. Word choices like 'could transform', 'multimorbidity', and 'in parallel' reinforce a narrative of high impact and broad applicability.
Overall positive stance; multiple posts echo potential benefits and transformative impact if proven safe/effective.
Moderate interest evident through reiteration of key points and emphasis on clinical potential.
Genuine engagement; quotes and paraphrase show the poster is processing the content rather than passively repeating.
Anticipatory optimism about broad, multi-disease benefits; some posts highlight systemic impact in geriatrics.
The Clinical Potential of Senolytic Drugs (2017) https://t.co/d9SM4EAWzW
The Clinical Potential of Senolytic Drugs. - PubMed - NCBI https://t.co/ffGXvcCClS
The Clinical Potential of Senolytic Drugs - Kirkland - 2017 - Journal of the American Geriatrics Society - Wiley Online Library https://t.co/VfsrgYwBoT
“Senolytic drugs are agents that selectively induce apoptosis of senescent cells. These cells accumulate in many tissues with aging and at sites of pathology in multiple chronic diseases.“ The Clinical Potential of Senolytic Drugs - Kirkland - https://t.co/xnlfgd6yyB
The Clinical Potential of Senolytic Drugs - Kirkland - 2017 - Journal of the American Geriatrics Society - Wiley Online Library https://t.co/s34gxIhxQz
4/ Senolytic drugs are agents that selectively destroy senescent cells or induce cell death. https://t.co/U93vCzSfp3
This episode explores how lifestyle choices and senolytic drugs influence cellular health and aging gracefully, focusing on decoding longevity, senescence, and the potential of senolytics for anti-aging therapies.
This episode explores cellular senescence, zombie cells, and the potential of senolytic drugs to promote longevity and healthy aging, highlighting recent research and clinical possibilities.
Explore the science of cellular aging, senescent cells, and senolytics. This episode discusses strategies to maintain cellular health, delay aging, and enhance longevity through targeted interventions.
An accessible explanation of human cellular aging: biological clocks, genetics vs environment, inflammaging, mitochondria, and what science can realistically do to slow aging.
Delving into the biology of aging, from cellular clocks to environment, inflammation, and mitochondria, and what the science says about slowing aging.
The Clinical Potential of Senolytic Drugs (2017) https://t.co/d9SM4EAWzW
The Clinical Potential of Senolytic Drugs - Kirkland - 2017 - Journal of the American Geriatrics Society - Wiley Online Library https://t.co/VfsrgYwBoT
The Clinical Potential of Senolytic Drugs https://t.co/VkPczu7szP
The Clinical Potential of Senolytic Drugs. - PubMed - NCBI https://t.co/ffGXvcCClS
The Clinical Potential of Senolytic Drugs - Kirkland - 2017 - Journal of the American Geriatrics Society - Wiley Online Library https://t.co/s34gxIhxQz
4/ Senolytic drugs are agents that selectively destroy senescent cells or induce cell death. https://t.co/U93vCzSfp3
“Senolytic drugs are agents that selectively induce apoptosis of senescent cells. These cells accumulate in many tissues with aging and at sites of pathology in multiple chronic diseases.“ The Clinical Potential of Senolytic Drugs - Kirkland - https://t.co/xnlfgd6yyB
“If senolytics prove to be effective and safe in clinical trials, they could transform geriatric medicine by enabling prevention or treatment of multiple diseases and functional deficits in parallel, instead of one at a time.“ https://t.co/EPUVUGlO08
Mayo Clinic - The Clinical Potential of Senolytic Drugs https://t.co/U93vCzSfp3
org/10.1111/jgs.14969 • Muñoz-Espín, D., & Serrano, M. (2014). Cellular senescence: from physiology to pathology. Nature Reviews Molecular ...
... Drugs https://doi.org/10.1111/jgs.14969. Markers of T Cell Senescence in Humans https://doi.org/10.3390/ijms18081742. [deleted]. •. 9y ago.
... 10.1111/jgs.14969). Dabei haben die potenziellen Arzneistoffe sogenannte seneszente Zellen als Ziel. Das sind Zellen, die sich nicht mehr ...
DOI: 10.1111/jgs.14969 (Review im «Journal of the American Geriatrics Society») DOI: 10.1038/ncomms15691 (Publikation in «Aging Cell ...
Journal of the American Geriatrics Society, 2017; DOI: 10.1111/jgs.14969; Joshua N Farr, Ming Xu, Megan M Weivoda, David G Monroe, Daniel G ...
The Clinical Potential of Senolytic Drugs... http://onlinelibrary.wiley. com/doi/10.1111/jgs.14969/abstract; ...